abstract |
The application discloses a compound or its stereoisomer or pharmaceutically acceptable salt, the compound has formula I, wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the application, and the compound is passed Acts on Tyk-2 to cause inhibition of signaling to regulate IL-12, IL-23 and/or IFNα. |